BRANDY HAMMOND: Open Payments
NPI 1659443745 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,988 in 60 payments from 8 companies in 2025. Trend: 2023 $1,269 · 2024 $954 · 2025 $1,988
Food & beverage: $1,878Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 23 | $755 |
| Janssen Pharmaceuticals, Inc | 10 | $327 |
| E.R. Squibb & Sons, L.L.C. | 7 | $309 |
| Vanda Pharmaceuticals Inc. | 9 | $235 |
| Alkermes, Inc. | 5 | $233 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Noven Therapeutics, LLC | 1 | $19 |
Products named: UZEDY, INVEGA SUSTENNA, COBENFY, FANAPT, AUSTEDO XR, LYBALVI, ABILIFY MAINTENA, ARISTADA.
Industry payments across AZ — which companies pay providers there.
